Marc R. Schneebaum
2021
Compensation breakdown
| Non-Equity Incentive Plan | $91,060 |
|---|---|
| Option Awards | $2,731,200 |
| Salary | $369,824 |
| Other | $512,705 |
| Total | $3,704,789 |
Schneebaum received $2.7M in option awards, accounting for 74% of the total pay in 2021.
Schneebaum also received $91.1K in non-equity incentive plan, $369.8K in salary and $512.7K in other compensation.
Rankings
In 2021, Marc R. Schneebaum's compensation ranked 3,605th out of 12,406 executives tracked by ExecPay. In other words, Schneebaum earned more than 70.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,605 out of 12,406 | 71st |
Division Manufacturing | 1,470 out of 5,492 | 73rd |
Major group Chemicals And Allied Products | 597 out of 2,368 | 75th |
Industry group Drugs | 531 out of 2,089 | 75th |
Industry Pharmaceutical Preparations | 372 out of 1,536 | 76th |
Pay ratio
| Marc R. Schneebaum's Pay | $3,704,789 |
|---|---|
| Median Employee's Pay | $459,419 |
| Pay Ratio | 8to 1 |
In 2021, the annual total compensation of Marc R. Schneebaum was $3,704,789.
The annual total compensation of the median employee at Synta Pharmaceuticals was $459,419.
The ratio of Marc R. Schneebaum's pay to the pay of median employee was therefore 8 to one.
Schneebaum's colleagues
We found five more compensation records of executives who worked with Marc R. Schneebaum at Synta Pharmaceuticals in 2021.
2021
Alex Howarth
Synta Pharmaceuticals
Chief Financial Officer
2021
Paul Friedman
Synta Pharmaceuticals
Chief Executive Officer
2021
Rebecca Taub
Synta Pharmaceuticals
Chief Medical Officer
2021
Brian Lynch
Synta Pharmaceuticals
General Counsel
2021
Remy Sukhija
Synta Pharmaceuticals